What does Janus Henderson Investors invest in?
Janus Henderson Investors invests most often at Series B and Series C (60% of the rounds on record), in sectors such as Credit, Payments and Asset Management.

United Kingdom · Investor
Last cheque observed Oct 2026; 178 cheques on record.
Deploying nowPrivate equity
Follow Janus Henderson Investors and see its new cheques in your feed.Start following
79 cheques in the last 12 months
Mostly Series B and Series C: 60% of its rounds
Sole investor in 4 rounds, median $33M
We provide access to some of the industry’s most talented and innovative thinkers.From their own website
Every round we can evidence, newest first178 appearances
63 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration13 named
We also hold 27 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
12 private funds, $6.7B in gross assets · filed Nov 2024
Hedge 6Liquidity 2Long only equity 2
And 2 more on the filing.
The investors most often in the same rounds as Janus Henderson Investors. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Janus Henderson Investors put money into.
2 episodes naming Janus Henderson Investors in the title, and 3 more that mention it.

[REPLAY] Daniel Graña – Janus Henderson Investors Emerging Markets Equity (Manager Meetings, EP.13)

Daniel Graña – Janus Henderson Investors Emerging Markets Equity (Manager Meetings, EP.13)

Thomas Haugaard - Hard Currency Emerging Markets Debt at JHI (EP.356)

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Janus Henderson Investors invests most often at Series B and Series C (60% of the rounds on record), in sectors such as Credit, Payments and Asset Management.
178 investments on record, 79 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.
Its most recent investments on record: Star Therapeutics (Undisclosed round, Oct 2026), OMass Therapeutics (Series C, Oct 2026) and Alaunos Therapeutics (Undisclosed round, Oct 2026).
The median round it joins is $115M.
Sometimes: it led 2 of its 178 investments on record (1%).
Most of the companies it backs are in the United States (85%) and the United Kingdom (8%).
Yes: it is actively investing, with 79 investments in the last 12 months.
Most often RA Capital Management (68 rounds together), Cormorant Asset Management (39 rounds together) and Wellington Management (30 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it